Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Blood (2017) 129 (11): 1548–1556.

https://doi.org/10.1182/blood-2016-10-745711

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation for Relapsed / Refractory (R/R) Follicular Lymphoma (FL). a Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)

Anna Sureda, MD PhD, Mei-Jie Zhang, PhD, Peter Dreger, MD, Jeanette Carreras, MPH, Timothy S. Fenske, MD, Herve Finel, Harry C. Schouten, MD PhD, Silvia Montoto, MD, Stephen Robinson, Sonali M. Smith, MD, Ariane Boumendil, PhD, Mehdi Hamadani, MD, Marcelo C. Pasquini, MD

Blood (2015) 126 (23): 198.

https://doi.org/10.1182/blood.V126.23.198.198

Published: 2015

Journal Articles

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

Alvaro Urbano-Ispizua, MD, Steven Z. Pavletic, MD, Mary E. D. Flowers, MD, Mei-Jie Zhang, PhD, Jeanette Carreras, MPH, Sonali M. Smith, MD, David G. Maloney, MD, PhD, Silvia Montoto, MD, Corey S. Cutler, MD, MPH, FRCPC, Stephen R Spellman, MBS, Mukta Arora, MD, MS, Wael Saber, MD, MS

Blood (2013) 122 (21): 2093.

https://doi.org/10.1182/blood.V122.21.2093.2093

Published: 2013

Journal Articles

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Veronika Bachanova, MD, Claudio Brunstein, MD, Linda J. Burns, MD, Tao Wang, PhD, Jeanette Carreras, MPH, Ginna G. Laport, MD, Sonali M. Smith, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Wael Saber, MD, MS

Blood (2013) 122 (21): 161.

https://doi.org/10.1182/blood.V122.21.161.161

Published: 2013

Journal Articles

Transplantation For Myelodysplastic Syndrome Evolving From Aplastic Anemia Treated With Immunosuppressive Therapy: From The Fred Hutchinson Cancer Research Center and Center For International Bone Marrow Transplantation Research

Sung-Yong Kim, MD, Jennifer Le Rademacher, PhD, Jeanette Carreras, MPH, Joseph H. Antin, MD, Paolo Anderlini, MD, Mouhab Ayas, MD, Minoo Battiwalla, MD, MS, Joanne Kurtzberg, MD, Ryotaro Nakamura, MD, Mary Eapen, MBBS, MS, H. Joachim Deeg, MD

Blood (2013) 122 (21): 924.

https://doi.org/10.1182/blood.V122.21.924.924

Published: 2013

Journal Articles

Impact of Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Grade-III Follicular (FL-III) and Diffuse Large B-Cell Lymphomas (DLBCL): A Cibmtr Analysis

Mehdi Hamadani, MD, Wael Saber, MD, MS, Jeanette Carreras, MPH, Kwang W. Ahn, PhD, Ginna G. Laport, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Hillard M. Lazarus, MD

Blood (2012) 120 (21): 473.

https://doi.org/10.1182/blood.V120.21.473.473

Published: 2012

Journal Articles

Effect of Graft Source and Transplant Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Mantle Cell Lymphoma (MCL): A Cibmtr Analysis

Mehdi Hamadani, MD, Wael Saber, MD, MS, Jeanette Carreras, MPH, Kwang W Ahn, PhD, Ginna G Laport, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Hillard M Lazarus, MD

Blood (2012) 120 (21): 815.

https://doi.org/10.1182/blood.V120.21.815.815

Published: 2012

Journal Articles

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Blood (2012) 120 (20): 4256–4262.

https://doi.org/10.1182/blood-2012-06-436725

Published: 2012

Includes: Supplemental data

Journal Articles

Conditioning Intensity in Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Diffuse Large B-Cell Lymphoma (DLBCL)

Ulrike Bacher, MD, Evgeny Klyuchnikov, MD, Jeanette Carreras, MPH, Jennifer Le-Rademacher, PhD, Ginna G. Laport, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 501.

https://doi.org/10.1182/blood.V118.21.501.501

Published: 2011

Journal Articles

A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL)

Theresa Hahn, PhD, Philip L. McCarthy, Jr., MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Hillard M. Lazarus, MD FACP, Ginna G. Laport, MD, Silvia Montoto, MD, David G. Maloney, MD, PhD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 499.

https://doi.org/10.1182/blood.V118.21.499.499

Published: 2011

Journal Articles

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

Mary Eapen, Jennifer Le Rademacher, Joseph H. Antin, Richard E. Champlin, Jeanette Carreras, Joseph Fay, Jakob R. Passweg, Jakub Tolar, Mary M. Horowitz, Judith C. W. Marsh, H. Joachim Deeg

Blood (2011) 118 (9): 2618–2621.

https://doi.org/10.1182/blood-2011-05-354001

Published: 2011

Includes: Supplemental data

Journal Articles

Effect of Stem Cell Source From Unrelated Donors on Transplant Outcomes In Severe Aplastic Anemia (SAA): a Comparison of Unrelated Bone Marrow (BM) and Peripheral Blood Progenitor Cells (PBPC)

Mary Eapen, MBBS, Jennifer LeRademacher, PhD, H. Joachim Deeg, Joseph H. Antin, MD, Richard Champlin, Jeanette Carreras, MPH, Joseph W. Fay, MD, Jakob R. Passweg, MD, MS, Jakub Tolar, MD, PhD, Judith C. W. Marsh, MD, Mary M. Horowitz, MD, MS

Blood (2010) 116 (21): 531.

https://doi.org/10.1182/blood.V116.21.531.531

Published: 2010

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (AHCT) for Primary Cutaneous T Cell Lymphoma (CTCL): a Center for International Blood and Marrow Transplant Research (CIBMTR) Review

Mary Jo Lechowicz, MD, Manza Agovi, MPH, Jeanette Carreras, MPH, Hillard M. Lazarus, MD, FACP, Ginna G. Laport, MD, Silvia Montoto, MD, David G Maloney, MD, PhD, Parameswaran Hari, MD

Blood (2010) 116 (21): 364.

https://doi.org/10.1182/blood.V116.21.364.364

Published: 2010

Journal Articles

The Role of Hematopoietic Cell Transplantation (HCT) for Burkitt Lymphoma: a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

James L. Gajewski, MD, Jeanette Carreras, MPH, Hillard M. Lazarus, MD, FACP, Ginna G. Laport, MD, Silvia Montoto, MD, David G. Maloney, Parameswaran Hari, MD

Blood (2010) 116 (21): 2390.

https://doi.org/10.1182/blood.V116.21.2390.2390

Published: 2010

Journal Articles

The Presence of HLA DR15 Antigen in Patients with Severe Aplastic Anemia Does Not Impact Engraftment and Survival After HLA-Identical Sibling Transplantation.

Minoo Battiwalla, MD, Tao Wang, PhD, Jeanette Carreras, MPH, H. Joachim Deeg, MD, Mouhab F. Ayas, MD, Rajinder P.S. Bajwa, MBBS, MD, Biju George, MD, Vikas Gupta, Ricardo Pasquini, Hubert Schrezenmeier, MD, Kirk R. Schultz, MD, Mary Eapen, MBBS

Blood (2009) 114 (22): 2280.

https://doi.org/10.1182/blood.V114.22.2280.2280

Published: 2009

Journal Articles

Comparison of Prognostic Models for Autologous Hematopoietic Stem Cell Transplantation (AHCT) for Relapsed Hodgkin Lymphoma.

Theresa Hahn, PhD, Philip L. McCarthy, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Hillard M. Lazarus, MD, Ginna G. Laport, MD, Silvia Montoto, MD, Parameswaran N Hari, MD

Blood (2009) 114 (22): 1215.

https://doi.org/10.1182/blood.V114.22.1215.1215

Published: 2009

Journal Articles

Hematopoietic Recovery and Overall Survival after HLA-Matched Sibling Transplants for Older Patients with Severe Aplastic Anemia (SAA).

Vikas Gupta, MD, MRCP, MRCPath, Jeanette Carreras, MPH, Ruta Bajorunaite, PhD, Robert Peter Gale, MD, PhD, DSc, Mitchell Sabloff, MDCM, FRCPC, MSc, Mahmoud Aljurf, MD, Hubert Schrezenmeier, MD, Gerard Socié, MD, Jakob Passweg, MD, MS, Olle Ringdén, MD, Ricardo Pasquini, MD, Judith Marsh, MD, Mary Eapen, MBBS

Blood (2008) 112 (11): 2169.

https://doi.org/10.1182/blood.V112.11.2169.2169

Published: 2008

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHCT) for Patients Relapsing after Autologous Stem Cell Transplantation (autoHCT) for B Cell Non-Hodgkin Lymphoma (NHL)

Cesar O Freytes, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Ginna G. Laport, MD, Koen Van Besien, MD, Hillard M. Lazarus, MD, Parameswaran Hari, MD, MS

Blood (2008) 112 (11): 459.

https://doi.org/10.1182/blood.V112.11.459.459

Published: 2008

Journal Articles

Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia.

John Horan, MD, Jeanette Carreras, MPH, Sergey Tarima, PhD, Bruce Camitta, MD, Robert Peter Gale, MD, PhD, Wolfgang Hintergerger, MD, Judith Marsh, MD, Ricardo Pasquini, MD, Marcelo Pasquini, MD, MS, Mark Walters, MD, Mary Eapen, MD, MS

Blood (2007) 110 (11): 1110.

https://doi.org/10.1182/blood.V110.11.1110.1110

Published: 2007

Journal Articles

Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL).

Timothy S. Fenske, MD, Parameswaran Hari, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Rammurti Kamble, MD, J. Douglas Rizzo, MD, MS, Koen van Besien, MD, Hillard M. Lazarus, MD, Julie M. Vose, MD

Blood (2007) 110 (11): 19.

https://doi.org/10.1182/blood.V110.11.19.19

Published: 2007

NARROW

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Allogeneic Stem Cell Transplantation for Relapsed / Refractory (R/R) Follicular Lymphoma (FL). a Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

Alternative Donor Transplantation For Adults With Lymphoma: Comparison Of Umbilical Cord Blood Versus 8/8 HLA-Matched Donor (URD) Versus 7/8 URD

Transplantation For Myelodysplastic Syndrome Evolving From Aplastic Anemia Treated With Immunosuppressive Therapy: From The Fred Hutchinson Cancer Research Center and Center For International Bone Marrow Transplantation Research

Impact of Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Grade-III Follicular (FL-III) and Diffuse Large B-Cell Lymphomas (DLBCL): A Cibmtr Analysis

Effect of Graft Source and Transplant Conditioning Regimen Intensity On the Outcomes of Allogeneic Hematopoietic Cell Transplantation for Refractory Mantle Cell Lymphoma (MCL): A Cibmtr Analysis

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Conditioning Intensity in Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Diffuse Large B-Cell Lymphoma (DLBCL)

A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL)

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

Effect of Stem Cell Source From Unrelated Donors on Transplant Outcomes In Severe Aplastic Anemia (SAA): a Comparison of Unrelated Bone Marrow (BM) and Peripheral Blood Progenitor Cells (PBPC)

Allogeneic Hematopoietic Cell Transplantation (AHCT) for Primary Cutaneous T Cell Lymphoma (CTCL): a Center for International Blood and Marrow Transplant Research (CIBMTR) Review

The Role of Hematopoietic Cell Transplantation (HCT) for Burkitt Lymphoma: a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

The Presence of HLA DR15 Antigen in Patients with Severe Aplastic Anemia Does Not Impact Engraftment and Survival After HLA-Identical Sibling Transplantation.

Comparison of Prognostic Models for Autologous Hematopoietic Stem Cell Transplantation (AHCT) for Relapsed Hodgkin Lymphoma.

Hematopoietic Recovery and Overall Survival after HLA-Matched Sibling Transplants for Older Patients with Severe Aplastic Anemia (SAA).

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHCT) for Patients Relapsing after Autologous Stem Cell Transplantation (autoHCT) for B Cell Non-Hodgkin Lymphoma (NHL)

Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia.

Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only